Clinical Trial

Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia

Study acronym: HairLight
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 29, 2023 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the prevention and management of chemotherapy-induced alopecia (CIA). Therefore, we hypothesize that PBMT can reduce the severity of CIA in gynecological and breast cancer patients, increasing the patient's QoL.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-12-14; most recent amendment 2023-09-28.
Status change: Not Yet Recruiting → Recruiting 2022-02-28
Trial Details
NCT Number NCT05177289
Lead Sponsor Jessa Hospital
Conditions Chemotherapy-induced Alopecia
Enrollment 72 participants
Start Date 2022-02-28
Primary Completion 2025-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2023-09-29